FDA Import Refusal FP1-0021113-4/61/1 — Crescent Pharma Ltd
The FDA refused shipment FP1-0021113-4/61/1 from Crescent Pharma Ltd (United Kingdom) on Mar 9, 2018. The refused product falls under Drugs and Biologics — METRONIDAZOLE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 9, 2018
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 62LCA40 METRONIDAZOLE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
- Charges
- 118,3280,75